Trial intelligence / Profile preview

Sildenafil for exercise- and hypoxia-induced pulmonary artery pressure in chronic heart failure

2008-008135-28Phase 4Terminated

Sponsor
Hull University Teaching Hospitals
Start
Apr 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of sildenafil in pulmonary hypertension (PH) and chronic heart failure (CHF) (2 arms), sponsored by Hull University Teaching Hospitals. Started Apr 2009; status: terminated.

02

Drugs

sildenafil
03

Conditions

pulmonary hypertension (PH)chronic heart failure (CHF)

Beyond the preview

Go deeper on 2008-008135-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-008135-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call